Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113880844 | 11388084 | 4 | F | 201507 | 20160727 | 20150817 | 20160812 | EXP | US-GLAXOSMITHKLINE-US2015116209 | GLAXOSMITHKLINE | 72.09 | YR | M | Y | 0.00000 | 20160812 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113880844 | 11388084 | 1 | PS | ANORO ELLIPTA | UMECLIDINIUM BROMIDEVILANTEROL TRIFENATATE | 1 | Respiratory (inhalation) | 1 PUFF(S), QD | R668888 | 203975 | 1 | DF | INHALATION POWDER | QD | |||||
| 113880844 | 11388084 | 2 | SS | ANORO ELLIPTA | UMECLIDINIUM BROMIDEVILANTEROL TRIFENATATE | 1 | Respiratory (inhalation) | 1 PUFF(S), QD | R691609 | 203975 | 1 | DF | INHALATION POWDER | QD | |||||
| 113880844 | 11388084 | 3 | SS | ANORO ELLIPTA | UMECLIDINIUM BROMIDEVILANTEROL TRIFENATATE | 1 | Respiratory (inhalation) | 62.5/25 MCG, 1 PUFF(S), QD | 6ZP3472 | 203975 | 1 | DF | INHALATION POWDER | QD | |||||
| 113880844 | 11388084 | 4 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 2 PUFF(S), PRN | 5ZP0167 | 0 | 2 | DF | |||||||
| 113880844 | 11388084 | 5 | C | COREG | CARVEDILOL | 1 | U | 0 | |||||||||||
| 113880844 | 11388084 | 6 | C | COUMADIN | WARFARIN SODIUM | 1 | U | 0 | |||||||||||
| 113880844 | 11388084 | 7 | C | NIASPAN | NIACIN | 1 | U | 0 | |||||||||||
| 113880844 | 11388084 | 8 | C | ZOCOR | SIMVASTATIN | 1 | U | 0 | |||||||||||
| 113880844 | 11388084 | 9 | C | AZELASTINE | AZELASTINE | 1 | U | 0 | |||||||||||
| 113880844 | 11388084 | 10 | C | ASPIRIN (BABY) | ASPIRIN | 1 | U | 0 | |||||||||||
| 113880844 | 11388084 | 11 | C | DIGOXIN. | DIGOXIN | 1 | U | 0 | |||||||||||
| 113880844 | 11388084 | 12 | C | LISINOPRIL. | LISINOPRIL | 1 | U | 0 | |||||||||||
| 113880844 | 11388084 | 13 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 113880844 | 11388084 | 14 | C | OXYGEN. | OXYGEN | 1 | U | 0 | |||||||||||
| 113880844 | 11388084 | 15 | C | LUTEIN | LUTEIN | 1 | 0 | ||||||||||||
| 113880844 | 11388084 | 16 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 113880844 | 11388084 | 17 | C | WARFARIN | WARFARIN | 1 | 0 | ||||||||||||
| 113880844 | 11388084 | 18 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 113880844 | 11388084 | 19 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 113880844 | 11388084 | 20 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113880844 | 11388084 | 1 | Chronic obstructive pulmonary disease |
| 113880844 | 11388084 | 4 | Dyspnoea |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113880844 | 11388084 | Blood glucose increased | |
| 113880844 | 11388084 | Dyspnoea | |
| 113880844 | 11388084 | Nasopharyngitis | |
| 113880844 | 11388084 | Product quality issue | |
| 113880844 | 11388084 | Rhinorrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113880844 | 11388084 | 1 | 201507 | 0 | ||
| 113880844 | 11388084 | 4 | 2013 | 0 |